ISIN | IE00BKWQ0H23 |
---|---|
Valor Number | 24767202 |
Bloomberg Global ID | |
Fund Name | SPDR MSCI Europe Health Care UCITS ETF EUR |
Fund Provider |
State Street Global Advisors
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Peculiarities |
Current Price * | 213.28 EUR | 01.04.2025 |
---|---|---|
Previous Price * | 211.79 EUR | 31.03.2025 |
52 Week High * | 247.60 EUR | 30.08.2024 |
52 Week Low * | 204.86 EUR | 20.12.2024 |
NAV * | 213.28 EUR | 01.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 656,647,911 | |
Unit/Share Assets *** | 656,647,911 | |
Trading Information SIX |
YTD Performance | +1.71% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
---|---|---|
YTD Performance (in CHF) | +3.53% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
1 month | -8.03% |
03.03.2025 - 01.04.2025
03.03.2025 01.04.2025 |
3 months | +0.90% |
02.01.2025 - 01.04.2025
02.01.2025 01.04.2025 |
6 months | -7.88% |
01.10.2024 - 01.04.2025
01.10.2024 01.04.2025 |
1 year | -0.18% |
02.04.2024 - 01.04.2025
02.04.2024 01.04.2025 |
2 years | +10.18% |
03.04.2023 - 01.04.2025
03.04.2023 01.04.2025 |
3 years | +8.16% |
01.04.2022 - 01.04.2025
01.04.2022 01.04.2025 |
5 years | +45.45% |
01.04.2020 - 01.04.2025
01.04.2020 01.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 16.40% | |
---|---|---|
AstraZeneca PLC | 13.24% | |
Roche Holding AG | 13.20% | |
Novartis AG Registered Shares | 12.13% | |
Sanofi SA | 7.02% | |
Essilorluxottica | 5.03% | |
GSK PLC | 4.34% | |
Alcon Inc | 2.62% | |
Lonza Group Ltd | 2.58% | |
Haleon PLC | 2.45% | |
Last data update | 28.02.2025 |
TER *** | 0.18% |
---|---|
TER date *** | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.18% |
Ongoing Charges *** | 0.18% |
SRRI ***
|
|
SRRI date *** | 28.02.2025 |